Karyopharm Therapeutics
Patents, Design & Utilities

Last updated:

List of all Karyopharm Therapeutics patents 27 in total

Status Patent
Application
Utility: PROCESS FOR PREPARING XPO1 INHIBITORS AND INTERMEDIATES FOR USE IN THE PREPARATION OF XPO1 INHIBITORS External link
Filling date: 26 Sep 2025 Issue date: 4 Aug 2022
Application
Utility: NUCLEAR TRANSPORT MODULATORS AND USES THEREOF External link
Filling date: 26 Sep 2025 Issue date: 9 Jun 2022
Application
Utility: BIOMARKERS FOR SELINEXOR External link
Filling date: 26 Sep 2025 Issue date: 9 Jun 2022
Application
Utility: IL-12 COMPOSITIONS AND METHODS OF USE IN HEMATOPOIETIC RECOVERY External link
Filling date: 26 Sep 2025 Issue date: 2 Jun 2022
Application
Utility: POLYMORPHS OF SELINEXOR External link
Filling date: 26 Sep 2025 Issue date: 5 May 2022
Application
Utility: HYDRAZIDE CONTAINING NUCLEAR TRANSPORT MODULATORS AND USES THEREOF External link
Filling date: 26 Sep 2025 Issue date: 10 Mar 2022
Application
Utility: NUCLEAR TRANSPORT MODULATORS AND USES THEREOF External link
Filling date: 26 Sep 2025 Issue date: 24 Feb 2022
Application
Utility: SUBSTITUTED BENZOFURANYL AND BENZOXAZOLYL COMPOUNDS AND USES THEREOF External link
Filling date: 26 Sep 2025 Issue date: 30 Dec 2021
Application
Utility: THE COMBINATION OF XPO1 INHIBITORS AND SECOND AGENTS FOR THE TREATMENT OF PROSTATE CANCER External link
Filling date: 26 Sep 2025 Issue date: 14 Oct 2021
Grant
Utility: Nuclear transport modulators and uses thereof External link
Filling date: 26 Sep 2025 Issue date: 21 Sep 2021
Grant
Utility: Polymorphs of selinexor External link
Filling date: 26 Sep 2025 Issue date: 3 Aug 2021
Grant
Utility: Hydrazide containing nuclear transport modulators and uses thereof External link
Filling date: 26 Sep 2025 Issue date: 15 Jun 2021
Grant
Utility: Substituted benzofuranyl and benzoxazolyl compounds and uses thereof External link
Filling date: 26 Sep 2025 Issue date: 18 May 2021
Grant
Utility: Multicyclic compounds and uses thereof External link
Filling date: 26 Sep 2025 Issue date: 8 Dec 2020
Application
Utility: HYDRAZIDE CONTAINING NUCLEAR TRANSPORT MODULATORS AND USES THEREOF External link
Filling date: 26 Sep 2025 Issue date: 29 Oct 2020
Application
Utility: POLYMORPHS OF SELINEXOR External link
Filling date: 26 Sep 2025 Issue date: 10 Sep 2020
Grant
Utility: Nuclear transport modulators and uses thereof External link
Filling date: 26 Sep 2025 Issue date: 14 Jul 2020
Application
Utility: NUCLEAR TRANSPORT MODULATORS AND USES THEREOF External link
Filling date: 26 Sep 2025 Issue date: 25 Jun 2020
Application
Utility: SUBSTITUTED BENZOFURANYL AND BENZOXAZOLYL COMPOUNDS AND USES THEREOF External link
Filling date: 26 Sep 2025 Issue date: 2 Apr 2020
Application
Utility: NUCLEAR TRANSPORT MODULATORS AND USES THEREOF External link
Filling date: 26 Sep 2025 Issue date: 19 Mar 2020
Grant
Utility: Hydrazide containing nuclear transport modulators and uses thereof External link
Filling date: 26 Sep 2025 Issue date: 28 Jan 2020
Grant
Utility: Nuclear transport modulators and uses thereof External link
Filling date: 26 Sep 2025 Issue date: 7 Jan 2020
Grant
Utility: Polymorphs of Selinexor External link
Filling date: 26 Sep 2025 Issue date: 31 Dec 2019
Application
Utility: HYDRAZIDE CONTAINING NUCLEAR TRANSPORT MODULATORS AND USES THEREOF External link
Filling date: 26 Sep 2025 Issue date: 31 Oct 2019
Grant
Utility: Nuclear transport modulators and uses thereof External link
Filling date: 26 Sep 2025 Issue date: 10 Sep 2019
Grant
Utility: Substituted benzofuranyl and benzoxazolyl compounds and uses thereof External link
Filling date: 26 Sep 2025 Issue date: 3 Sep 2019
Grant
Utility: (S,E)-3-(6-aminopyridin-3-yl)-N-((5-(4-(3-fluoro-3-methylpyrrolidine-1-car- bonyl)phenyl-7-(4-fluorophenyl)benzofuran-2-yl)methyl)acrylamide for the treatment of cancer External link
Filling date: 26 Sep 2025 Issue date: 30 Jul 2019

Showing 1 to 27 of 27 patents.